Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Intuitive Surgical, Inc. (NASDAQ:ISRG). In a filing disclosed on January 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Intuitive Surgical stock on December 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 12/30/2025.
- Sold $1,001 – $15,000 in shares of Schneider Electric S.E. (OTCMKTS:SBGSF) on 12/30/2025.
- Sold $1,001 – $15,000 in shares of Hermès International Société en commandite par actions (OTCMKTS:HESAF) on 12/30/2025.
- Purchased $50,001 – $100,000 in shares of Campbell’s (NASDAQ:CPB) on 12/30/2025.
- Sold $1,001 – $15,000 in shares of Tencent (OTC:TCTZF) on 12/30/2025.
- Sold $1,001 – $15,000 in shares of Mitsubishi Heavy Industries (OTCMKTS:MHVYF) on 12/26/2025.
- Sold $1,001 – $15,000 in shares of Bloom Energy (NYSE:BE) on 12/24/2025.
- Sold $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 12/24/2025.
- Sold $1,001 – $15,000 in shares of Coinbase Global (NASDAQ:COIN) on 12/24/2025.
- Sold $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 12/24/2025.
Intuitive Surgical Trading Down 1.0%
Shares of NASDAQ:ISRG traded down $5.42 during trading on Thursday, reaching $541.34. The company’s stock had a trading volume of 1,899,694 shares, compared to its average volume of 1,900,795. The stock has a market capitalization of $194.06 billion, a PE ratio of 71.61, a price-to-earnings-growth ratio of 4.57 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm’s 50 day simple moving average is $566.95 and its two-hundred day simple moving average is $512.09.
Insider Transactions at Intuitive Surgical
In related news, EVP Myriam Curet sold 104 shares of the business’s stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the sale, the senior vice president owned 131 shares of the company’s stock, valued at approximately $71,852.19. This trade represents a 77.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Intuitive Surgical
Institutional investors have recently added to or reduced their stakes in the stock. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Tobam boosted its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical in the second quarter worth $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $28,000. Finally, Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical during the second quarter worth $30,000. Institutional investors own 83.64% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Evercore ISI set a $580.00 target price on shares of Intuitive Surgical in a research note on Monday, January 5th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Barclays restated an “overweight” rating and issued a $686.00 target price (up from $635.00) on shares of Intuitive Surgical in a research note on Wednesday, January 7th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research note on Friday, January 9th. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $622.17.
View Our Latest Stock Analysis on ISRG
Key Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Preliminary Q4 and full‑year 2025 results beat expectations — revenue and procedure growth were strong, supporting underlying demand and margin strength. Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
- Positive Sentiment: Management said da Vinci system usage “exceeded expectations” in places and signaled continued demand for more systems and consumables, a tailwind for recurring revenue. Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
- Positive Sentiment: Analysts remain constructive — Bernstein reiterated a Buy and William Blair maintained a Buy, citing DV5 adoption and the innovation pipeline as reasons to support premium valuation. Bernstein Sticks to Their Buy Rating for Intuitive Surgical (ISRG) DV5 Adoption, Innovation Pipeline Support Buy Rating
- Positive Sentiment: Pipeline progress: IS-001 Phase 3 update highlights an imaging‑driven safety play that could expand the company’s safety/adjunct portfolio if successful. IS-001 Phase 3 Update
- Neutral Sentiment: da Vinci 5 international rollout is underway, but adoption outside the U.S. faces pricing, budget and reimbursement hurdles — a longer ramp could delay overseas growth. da Vinci 5 Expands Globally
- Negative Sentiment: Investors reacted negatively because management’s 2026 da Vinci growth projection came in below some expectations, prompting concerns about slowing unit placement cadence even after a strong quarter. da Vinci Growth Projection Misses Expectations
- Negative Sentiment: High valuation and investor sensitivity to any slowing growth (ISRG trades at a premium P/E) amplified the selloff despite the beat. Commentary and headlines framed the reaction as “crushed forecasts but shares dived,” driving short‑term selling. Why Intuitive Surgical Stock Dropped Today
- Negative Sentiment: Multiple news writeups explain the stock’s drop today — overall market reaction centered on forward outlook and valuation rather than the quarter’s beats. Why Intuitive Surgical Stock Is Falling Today
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
